VNRX - VolitionRx Limited (VNRX) CEO Cameron Reynolds on Q4 2021 Results - Earnings Call Transcript

VolitionRx Limited (VNRX) Q4 2021 Results Conference Call March 31, 2022 08:00 AM ET Company Participants Scott Powell - Executive Vice President of Investor Relations Cameron Reynolds - President and Chief Executive Officer Terig Hughes - Chief Financial Officer Tom Butera - Chief Executive Officer, Volition Veterinary Diagnostics Development Conference Call Participants Ross Osborn - Cantor Fitzgerald Bruce Jackson - The Benchmark Company Nathan Weinstein - Aegis Capital Michael Okunewitch - Maxim Presentation Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited's Fourth Quarter and Full Year 2021 Earnings Conference Call. [Operator Instructions] This conference is being recorded today, March 31, 2022. I would now like to turn the conference call over to Scott Powell, Executive Vice President of Investor Relations. Please go ahead. Scott Powell Thank you, and welcome, everyone, to today's earnings conference call for VolitionRx Limited. This call will cover Volition's

For further details see:

VolitionRx Limited (VNRX) CEO Cameron Reynolds on Q4 2021 Results - Earnings Call Transcript